These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37130223)

  • 1. Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis.
    Wang Q; Xie Z; Wan N; Yang L; Jin Z; Jin F; Huang Z; Chen M; Wang H; Feng J
    Chin Med J (Engl); 2023 Jun; 136(11):1278-1290. PubMed ID: 37130223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
    Aoshima Y; Enomoto Y; Muto S; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Lung; 2021 Jun; 199(3):289-298. PubMed ID: 33770226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers and their potential functions in idiopathic pulmonary fibrosis.
    Ni S; Song M; Guo W; Guo T; Shen Q; Peng H
    Expert Rev Respir Med; 2020 Jun; 14(6):593-602. PubMed ID: 32187497
    [No Abstract]   [Full Text] [Related]  

  • 7. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical management of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):90-8. PubMed ID: 26278687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons.
    Jee AS; Sahhar J; Youssef P; Bleasel J; Adelstein S; Nguyen M; Corte TJ
    Pharmacol Ther; 2019 Oct; 202():40-52. PubMed ID: 31153954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
    Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
    Front Immunol; 2022; 13():810338. PubMed ID: 35185901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.
    Vercauteren IM; Verleden SE; McDonough JE; Vandermeulen E; Ruttens D; Lammertyn EJ; Bellon H; De Dycker E; Dooms C; Yserbyt J; Verleden GM; Vanaudenaerde BM; Wuyts WA
    Exp Lung Res; 2015; 41(8):459-65. PubMed ID: 26381718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
    Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.
    Veeraraghavan S; Latsi PI; Wells AU; Pantelidis P; Nicholson AG; Colby TV; Haslam PL; Renzoni EA; du Bois RM
    Eur Respir J; 2003 Aug; 22(2):239-44. PubMed ID: 12952254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding the role of fatty acids and their metabolites in lung fibrosis.
    Wygrecka M; Hadzic S; Potaczek DP; Alexopoulos I; El Agha E; Schaefer L
    Pol Arch Intern Med; 2023 Jun; 133(7-8):. PubMed ID: 37387676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis.
    Buendía-Roldán I; Ruiz V; Sierra P; Montes E; Ramírez R; Vega A; Salgado A; Vargas MH; Mejía M; Pardo A; Selman M
    PLoS One; 2016; 11(12):e0168552. PubMed ID: 27977812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?
    Elhai M; Avouac J; Allanore Y
    Semin Arthritis Rheum; 2020 Jun; 50(3):480-491. PubMed ID: 32089354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions.
    Stainer A; Faverio P; Busnelli S; Catalano M; Della Zoppa M; Marruchella A; Pesci A; Luppi F
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
    Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
    Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.
    Maldonado M; Buendía-Roldán I; Vicens-Zygmunt V; Planas L; Molina-Molina M; Selman M; Pardo A
    PLoS One; 2018; 13(9):e0203779. PubMed ID: 30208119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.